Edition:
United Kingdom

People: Catalyst Biosciences Inc (CBIO.OQ)

CBIO.OQ on NASDAQ Stock Exchange Capital Market

8.43USD
17 Jul 2019
Change (% chg)

$-0.18 (-2.09%)
Prev Close
$8.61
Open
$8.55
Day's High
$8.68
Day's Low
$8.42
Volume
22,638
Avg. Vol
56,497
52-wk High
$13.30
52-wk Low
$6.20

Hunt, Andrea 

Ms. Andrea Hunt is Director of the Company. Ms. Andrea Hunt was most recently vice president, New Product Gene Therapy, Neuroscience, Oncology & Ophthalmology at Shire, Plc., where she was developing and integrating strategies for Shire's gene therapy platform. Ms. Hunt came to Shire through its acquisition of Baxalta, where she led the Global Blood Disorders Franchise within the Hematology Division. Prior to Baxalta, Ms. Hunt held several positions of increasing responsibility at Baxter Healthcare leading to her appointment as project leader to Baxter Healthcare's R&D program, BAX855, now Adynovate™. Ms. Hunt served on the board for the Alliance for Regenerative Medicine and is an advisor to the Angiogenesis Foundation. Ms. Hunt earned her MBA in marketing from the University of Michigan and her B.S. in hospital dietetics and B.A. in foods and nutrition from the University of Illinois.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --